Chemours Investors Face December 7 Deadline in Securities Class Action
Faruqi & Faruqi reminds Chemours investors of a securities class action lawsuit deadline on December 7, 2026.
Related stories
Medline to Remove or Correct Branded Beds and Accessories Over Safety Risks
The FDA says Medline is discontinuing and removing or correcting branded beds and accessories over safety risks.
M impact | REGULATION | Oct 29, 2026, 04:36 PM UTC
Ohio AG Seeks $220 Million From GM Over Alleged Data Sales
Ohio Attorney General says General Motors was asked to pay $220 million over the alleged sale of consumers’ driving behavior and location data.
M impact | REGULATION | Oct 29, 2026, 04:31 PM UTC
Venezuela to Offer State Assets to Private Sector, Rodriguez Says
M impact | REGULATION | Oct 29, 2026, 04:28 PM UTC
GM to Pay to Resolve Consumer Privacy Allegations
GM will pay to resolve allegations that it violated consumers’ privacy.
M impact | REGULATION | Oct 29, 2026, 04:25 PM UTC
GM Reaches Consumer Privacy Settlement
Washington state’s attorney general said General Motors agreed to a settlement over consumer privacy violations involving personal data on driving behavior and location information
M impact | REGULATION | Oct 29, 2026, 04:25 PM UTC
FDA Warns on Medline Beds After Two Deaths, 16 Serious Injuries
The US FDA issued a warning concerning Medline beds after two deaths and 16 serious injuries.
M impact | REGULATION | Oct 29, 2026, 04:23 PM UTC